Some patients qualify for savings programs, while others do not
There is a steadily growing demand for weight loss medications
While these trials were not specifically designed to assess joint pain, patients with obesity-related joint pain who achieve significant weight loss through GLP-1 therapy often report improved mobility, reduced need for analgesics, and enhanced ability to engage in physical activitycreating a positive cycle of further weight management and joint health
The Precision Peptide Genetic Test (add-on, $99 after first month) identifies genetic variants in GLP1R and MC4R pathways that may predispose you to stronger or longer-lasting nausea, allowing your provider to anticipate your response and personalize your protocol upfront
Tirzepatide is a relatively new medication, and more research is also needed on the potential long-term effects
Consistent treatments can help maintain results, while occasional sessions can provide a quick boost